The medicines regulator, Swissmedic, has given the go ahead to the one-shot vaccine from the US company Johnson and Johnson.
Sometimes known as the Janssen Vaccine, it has a 66.9% efficacy rate in those over 18 years old.
The drug was put forward for authorisation in December.
The vaccine has been used in the United States since February.
As yet, there’s no information when it will start to be used.
Parliament rejects WHO alcohol policy
Cyclist dies near the UN
Govt may buy fewer F-35s due to cost
Amnesty slams Bern police
Two men given house arrest after stealing vignettes
What's likely under the tree this year?
